NO991717L - Trunkert blodplateaktiverende faktor-acetylhydrolase - Google Patents

Trunkert blodplateaktiverende faktor-acetylhydrolase

Info

Publication number
NO991717L
NO991717L NO991717A NO991717A NO991717L NO 991717 L NO991717 L NO 991717L NO 991717 A NO991717 A NO 991717A NO 991717 A NO991717 A NO 991717A NO 991717 L NO991717 L NO 991717L
Authority
NO
Norway
Prior art keywords
activating factor
platelet activating
acetyl hydrolase
factor acetyl
truncated
Prior art date
Application number
NO991717A
Other languages
English (en)
Other versions
NO991717D0 (no
NO326968B1 (no
Inventor
Lawrence S Cousens
Christine D Eberhardt
Patrick Gray
Hai Le Trong
Larry W Tjoelker
Cheryl L Wilder
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Priority to NO19991717A priority Critical patent/NO326968B1/no
Publication of NO991717D0 publication Critical patent/NO991717D0/no
Publication of NO991717L publication Critical patent/NO991717L/no
Publication of NO326968B1 publication Critical patent/NO326968B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01047—1-Alkyl-2-acetylglycerophosphocholine esterase (3.1.1.47), i.e. platelet-activating factor acetylhydrolase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19991717A 1997-08-13 1999-04-12 PAF-AH-polypeptidfragment, isolert polynukleotid, DNA-vektor, vertscelle, fremgangsmate for fremstilling av et PAF-AH-polypeptidfragment, en variant eller et variant-fragment av plasma-PAF-AH, PAF-AH-polypeptidfragment, variant eller variantfragment, farmasoytisk preparat, anvendelse av PAF-AH-fragmentet, varianten eller variantfragmentet for fremstilling av et medikament for behandling av et pattedyr. NO326968B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO19991717A NO326968B1 (no) 1997-08-13 1999-04-12 PAF-AH-polypeptidfragment, isolert polynukleotid, DNA-vektor, vertscelle, fremgangsmate for fremstilling av et PAF-AH-polypeptidfragment, en variant eller et variant-fragment av plasma-PAF-AH, PAF-AH-polypeptidfragment, variant eller variantfragment, farmasoytisk preparat, anvendelse av PAF-AH-fragmentet, varianten eller variantfragmentet for fremstilling av et medikament for behandling av et pattedyr.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1997/014212 WO1999009147A1 (en) 1997-08-13 1997-08-13 Truncated platelet-activating factor acetylhydrolase
NO19991717A NO326968B1 (no) 1997-08-13 1999-04-12 PAF-AH-polypeptidfragment, isolert polynukleotid, DNA-vektor, vertscelle, fremgangsmate for fremstilling av et PAF-AH-polypeptidfragment, en variant eller et variant-fragment av plasma-PAF-AH, PAF-AH-polypeptidfragment, variant eller variantfragment, farmasoytisk preparat, anvendelse av PAF-AH-fragmentet, varianten eller variantfragmentet for fremstilling av et medikament for behandling av et pattedyr.

Publications (3)

Publication Number Publication Date
NO991717D0 NO991717D0 (no) 1999-04-12
NO991717L true NO991717L (no) 1999-06-11
NO326968B1 NO326968B1 (no) 2009-03-23

Family

ID=22261441

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991717A NO326968B1 (no) 1997-08-13 1999-04-12 PAF-AH-polypeptidfragment, isolert polynukleotid, DNA-vektor, vertscelle, fremgangsmate for fremstilling av et PAF-AH-polypeptidfragment, en variant eller et variant-fragment av plasma-PAF-AH, PAF-AH-polypeptidfragment, variant eller variantfragment, farmasoytisk preparat, anvendelse av PAF-AH-fragmentet, varianten eller variantfragmentet for fremstilling av et medikament for behandling av et pattedyr.

Country Status (12)

Country Link
EP (1) EP0948605A1 (no)
JP (1) JP2001502163A (no)
AU (1) AU751594B2 (no)
BR (1) BR9711882A (no)
CA (1) CA2267994C (no)
CZ (1) CZ297603B6 (no)
HU (1) HUP9903959A3 (no)
IL (3) IL129262A0 (no)
NO (1) NO326968B1 (no)
PL (1) PL190532B1 (no)
SK (1) SK286518B6 (no)
WO (1) WO1999009147A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000649A1 (en) 1993-06-25 1995-01-05 Smithkline Beecham Plc Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
EP1294943A2 (en) * 2000-01-20 2003-03-26 Genome Therapeutics Corporation RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE
CN103891709A (zh) * 2012-12-24 2014-07-02 深圳先进技术研究院 细胞冻存液及细胞冻存方法
WO2022120784A1 (zh) * 2020-12-11 2022-06-16 深圳上泰生物工程有限公司 一种组合物及其在检测脂蛋白相关磷脂酶a2活性中的应用
CN112575057B (zh) * 2020-12-11 2021-07-30 深圳上泰生物工程有限公司 一种组合物及其在检测脂蛋白相关磷脂酶a2活性中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000649A1 (en) * 1993-06-25 1995-01-05 Smithkline Beecham Plc Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
EP1096016B1 (en) * 1993-10-06 2006-01-11 Icos Corporation Platelet-activating factor acetylhydrolase
JPH11514228A (ja) * 1995-09-29 1999-12-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー リポ蛋白結合ホスホリパーゼＡ２（Ｌｐ−ＰＬＡ２）ＰＡＦアセチルヒドロラーゼに対して配列相同性を有する化合物
WO1997012963A2 (en) * 1995-09-29 1997-04-10 Smithkline Beecham Plc A paf-acetylhydrolase and use in therapy
JPH1017600A (ja) * 1996-06-28 1998-01-20 Suntory Ltd 血小板活性化因子アセチルヒドロラーゼおよびその遺伝子

Also Published As

Publication number Publication date
HUP9903959A3 (en) 2002-01-28
EP0948605A1 (en) 1999-10-13
IL173867A0 (en) 2006-07-05
JP2001502163A (ja) 2001-02-20
PL332833A1 (en) 1999-10-11
NO991717D0 (no) 1999-04-12
SK286518B6 (sk) 2008-12-05
NO326968B1 (no) 2009-03-23
CA2267994A1 (en) 1999-02-25
CZ124199A3 (cs) 2000-06-14
AU3978297A (en) 1999-03-08
AU751594B2 (en) 2002-08-22
IL129262A0 (en) 2000-02-17
HUP9903959A2 (hu) 2000-03-28
WO1999009147A1 (en) 1999-02-25
CZ297603B6 (cs) 2007-02-07
SK47399A3 (en) 2000-11-07
CA2267994C (en) 2005-04-12
PL190532B1 (pl) 2005-12-30
IL129262A (en) 2006-06-11
BR9711882A (pt) 1999-09-21

Similar Documents

Publication Publication Date Title
DE69805538D1 (de) Verteilte virtuelle umgebung
DE69832623D1 (de) Mikrogefertigte kreisel
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
ATA93198A (de) Fluoxetinpellets
ID24314A (id) Tempat umpan bersekat-sekat
DE69808855D1 (de) Klebstoff
DK94897A (da) Propeller
DE69812823D1 (de) Postannulierungsmaschine
DE69811489D1 (de) Kohlenstoff-siliciumcarbid-verbundwerkstoff
DE59809001D1 (de) Ultraschallsensor
DE69810444D1 (de) Polarisationserhaltende faseroptische baugruppe
DE59810709D1 (de) Schallwandlersystem
DE69818003D1 (de) Verbindungstruktur
ATE236897T1 (de) 3-benzylpiperidine
NO991717D0 (no) Trunkert blodplateaktiverende faktor-acetylhydrolase
DE59804489D1 (de) Einschlagdübel
DE69840513D1 (de) Beschallungsanlage
ATA112597A (de) Snowboard - bindung
DE69825437D1 (de) Beschleunigungsaufnehmer
DE59808611D1 (de) Einschlagdübel
DE69817539D1 (de) Pc-chipanordnungverbindungsbus
ATE238786T1 (de) Anti-first-pass-effect-substanzen
ID20897A (id) Susunan penutup-rapat
PT862024E (pt) Desumidificador
ATA86797A (de) Verschleissschuh

Legal Events

Date Code Title Description
MK1K Patent expired